Journey Clinical is on a mission to expand access to transformative, evidence-based psychedelic therapies, starting with Ketamine-Assisted Psychotherapy (KAP).
“I used psychedelics to treat my PTSD after other treatments failed. My experience using these medicines with therapy led me to found my own company.” Jonathan Sabbagh, CEO of Journey Clinical Read More on Business Insider
Journey Medical
